简体中文 | 繁體中文 | English

Delphi genetics

Delphi Genetics SA Obtained the ISO 9001:2008 Certification, Confirming the Company’s High Standards of Quality in Customer Services Delivery and Research Kits Production

2010-01-13 22:00
  • zh_cn
  • zh_hant
  • en

Delphi Genetics Obtains ISO 9001 Certification

CHARLEROI, Belgium -- (BUSINESS WIRE) --

Delphi Genetics (www.delphigenetics.com), the company developing innovative tools and technologies for genetic engineering, announces today that it received recently the ISO 9001: 2008 certification, demonstrating its high standards of quality in providing DNA engineering customer services and innovative research kits. Through this new development, Delphi Genetics confirms its position as a reliable, innovative and organized business partner.

The ISO 9001:2008 standard specifies Quality Management System (QMS) requirements regarding an organization's ability to improve upon their products and services quality. In the course of the certification process, Delphi Genetics proved it had implemented the necessary standards and procedures to regularly, quantifiably and verifiably deliver quality products and customer services, while applying a systematic approach towards overall quality management.

"Since the ISO certification is only obtained after a thorough analysis by an independent authority, it stands as a recognition of Delphi Genetics' excellence in providing its customers and business partners with quality products and tailor-made services. This certification highlights the management quality of a company thriving on an outstanding innovative spirit", said Philippe Gabant, Delphi Genetics CEO.

Recently, Delphi Genetics announced a licensing agreement with Sanofi Pasteur for the use of its antibiotic-free Staby® technology for the production of human recombinant vaccines.

About Delphi Genetics SA

Founded in 2001, Delphi Genetics develops new and more effective products and technologies for gene cloning and protein expression in bacteria by exploiting its expertise in bacterial selection genes. Delphi Genetics' patented antibiotic-free Staby® technology improves protein expression efficiency and enables successful production of recombinant proteins which are impossible to produce using standard methods.

Moreover, Delphi Genetics provides a broad range of tailor-made services in the fields of genetic engineering and protein production.

For more information please visit http://www.delphigenetics.com.

 

CONTACT:

Delphi Genetics SA
delphigenetics@delphigenetics.com
Tel: +32 71 37 85 25